Who invested in Lifordi Immunotherapeutics?
Lifordi Immunotherapeutics's investors include Atlas Venture, ARCH Venture Partners, 5AM Ventures and Sanofi.
United States · Venture startup
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 12 months ago
Funding summaryUpdated 26 Oct 2026
$42Mraised across 1 round since 2025, from 1 source
Lifordi Immunotherapeutics's investors include Atlas Venture, ARCH Venture Partners, 5AM Ventures and Sanofi.
Lifordi Immunotherapeutics has raised $42M across 1 round since 2025.
Lifordi Immunotherapeutics's most recent round was a Venture of $42M in Nov 2025.
Its most recent round, $42M in Nov 2025, is also its largest on record.
Lifordi Immunotherapeutics's first round on record, in Nov 2025, was backed by Atlas Venture, ARCH Venture Partners and 5AM Ventures and 1 others.
Lifordi Immunotherapeutics's latest named round is a Venture, in Nov 2025.
Lifordi Immunotherapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.